Pura Vida Investments, LLC Iveric Bio, Inc. Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$17.24 - $23.95 $3.58 Million - $4.97 Million	207,545 Added 21.28%	1,182,975 $25.3 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $2.45 Million - $4.84 Million	260,286 Added 36.4%	975,430 $17.5 Million
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $1.37 Million - $2.84 Million	-150,000 Reduced 17.34%	715,144 $6.88 Million
Q1 2022 May 16, 2022	SELL	$12.15 - $16.83 $295,366 - $409,137	-24,310 Reduced 2.73%	865,144 $14.6 Million
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $11.9 Million - $16.1 Million	857,689 Added 2700.11%	889,454 $14.9 Million
Q3 2021 Nov 15, 2021	SELL	$7.07 - $17.5 $115,241 - $285,250	-16,300 Reduced 33.91%	31,765 $516,000
Q2 2021 Aug 16, 2021	BUY	$5.69 - $7.17 $273,489 - $344,626	48,065 New	48,065 $303,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.